<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02846779</url>
  </required_header>
  <id_info>
    <org_study_id>2016P000648</org_study_id>
    <nct_id>NCT02846779</nct_id>
  </id_info>
  <brief_title>Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes</brief_title>
  <acronym>TARGIT-DM</acronym>
  <official_title>Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes (TARGIT-DM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Horizon Blue Cross Blue Shield of New Jersey</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate three pharmacist-outreach strategies for improving
      adherence to insulin among individuals with diabetes. The three approaches are
      equivalently-priced but vary by degree of targeting and intervention intensity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In an era of rapidly growing healthcare costs, due to in large part to the increasing burden
      and complexity of chronic disease management, targeting outreach to patients who are most
      likely to benefit from them and tailoring interventions to individual patient needs,
      represent important opportunities to maximize healthcare value. The Targeted Adherence
      intervention to Reach Glycemic control with Insulin Therapy for patients with Diabetes
      (TARGIT-DM) trial is a pragmatic, intention-to-treat, randomized-controlled study that will
      evaluate the impact of three equivalently-priced strategies to improve insulin persistence
      and glycosylated hemoglobin [HbA1c] control among patients with diabetes on insulin.

      The interventions in each of the three study arms will consist of educational mailings and
      telephonic pharmacist outreach. The pharmacists will assess and address potential barriers to
      insulin adherence and optimal glycemic control. The three study arms will employ differ both
      in regards to which patients are targeted and the intensity of the engagement strategy used.
      The low intensity intervention in arm 1 will be deployed to all subjects randomized to that
      arm. The moderate and high intensity interventions will be delivered to focused populations
      within arms 2 and 3, respectively, as defined by poor disease control and/or predicted risk
      of non-adherence. The interventions provided in the moderate and high intensity arms will
      also include feedback to the patient's provider, as needed, and potential enrollment in a
      text messaging program. Patients in these two arms who are not targeted will receive usual
      care.

      The study population for this trial will consist of members enrolled in commercial insurance
      provided by Horizon Blue Cross Blue Shield of New Jersey. Insurance claims data will be used
      to apply the inclusion and exclusion criteria. Eligible patients will be randomized into one
      of three arms, stratified by baseline availability of HbA1c and a valid telephone number.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">February 10, 2018</completion_date>
  <primary_completion_date type="Actual">December 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin Persistence</measure>
    <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
    <description>Percentage of participants who were non-persistent if they did not refill insulin before a set threshold of time over the entire follow-up period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Glycated Hemoglobin Level (HbA1c)</measure>
    <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
    <description>The percent change in HbA1c level between the latest baseline value to the latest follow up value, among those with at least 1 baseline HbA1c available.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Care Spending</measure>
    <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
    <description>Health care spending includes prescription medications, nondrug medical services, and the combination of these two factors over the entire follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Physician Office Visits</measure>
    <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
    <description>Number of all-cause physician office visits over the entire follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Emergency Room Visits</measure>
    <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
    <description>Number of all-cause emergency room visits over the entire follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Hospitalizations</measure>
    <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
    <description>Number of All-cause hospitalizations over the entire follow-up period</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">6000</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Low intensity</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All participants randomized to this arm will receive quarterly educational mailings and limited telephonic outreach delivered by a pharmacist focused on insulin adherence and glycemic control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate intensity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive all intervention components as in the low-intensity arm but will receive more frequent pharmacist follow-up and the option of enrolling in a text-messaging program. The pharmacist will also provide limited follow-up with the participant's provider. Only 60% of participants randomized will be targeted to receive the intervention based on adherence risk score.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High intensity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive all intervention components as in the moderate-intensity arm but will receive more frequent pharmacist follow-up. The pharmacist will also provide more follow-up with the participant's provider and/or pharmacist. Only 40% of participants randomized will be targeted to receive the intervention based on adherence risk score and baseline disease control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low intensity</intervention_name>
    <description>Low intensity telepharmacy outreach</description>
    <arm_group_label>Low intensity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate intensity</intervention_name>
    <description>Moderate intensity telepharmacy outreach</description>
    <arm_group_label>Moderate intensity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High intensity</intervention_name>
    <description>High intensity telepharmacy outreach</description>
    <arm_group_label>High intensity</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Commercially-insured individuals receiving medical and pharmacy health insurance
             benefits from Horizon Blue Cross Blue Shield of New Jersey

          -  At least 3 months of continuous enrollment prior to randomization

          -  At least 1 prescription for basal insulin, 6 months prior to randomization

          -  Type 2 diabetes diagnosis

        Exclusion Criteria:

          -  Patients with Medicaid or Medicare as primary insurance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niteesh K Choudhry, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Horizon Blue Cross Blue Shield of New Jersey</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07105-2200</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 25, 2016</study_first_submitted>
  <study_first_submitted_qc>July 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2016</study_first_posted>
  <results_first_submitted>March 5, 2019</results_first_submitted>
  <results_first_submitted_qc>August 5, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 7, 2019</results_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Niteesh K. Choudhry, MD, PhD</investigator_full_name>
    <investigator_title>Associate Professor, Harvard Medical School and Executive Director, Center for Healthcare Delivery Sciences, Department of Medicine, Brigham and Women's Hospital</investigator_title>
  </responsible_party>
  <keyword>Insulin persistence</keyword>
  <keyword>Telepharmacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 4, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/79/NCT02846779/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Low Intensity</title>
          <description>All participants randomized to this arm will receive quarterly educational mailings and limited telephonic outreach delivered by a pharmacist focused on insulin adherence and glycemic control.
Low intensity: Low intensity telepharmacy outreach</description>
        </group>
        <group group_id="P2">
          <title>Moderate Intensity</title>
          <description>Participants will receive all intervention components as in the low-intensity arm but will receive more frequent pharmacist follow-up and the option of enrolling in a text-messaging program. The pharmacist will also provide limited follow-up with the participant’s provider. Only 60% of participants randomized will be targeted to receive the intervention based on adherence risk score.
Moderate intensity: Moderate intensity telepharmacy outreach</description>
        </group>
        <group group_id="P3">
          <title>High Intensity</title>
          <description>Participants will receive all intervention components as in the moderate-intensity arm but will receive more frequent pharmacist follow-up. The pharmacist will also provide more follow-up with the participant’s provider and/or pharmacist. Only 40% of participants randomized will be targeted to receive the intervention based on adherence risk score and baseline disease control.
High intensity: High intensity telepharmacy outreach</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2000"/>
                <participants group_id="P2" count="2000"/>
                <participants group_id="P3" count="2000"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1861"/>
                <participants group_id="P2" count="1873"/>
                <participants group_id="P3" count="1862"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="139"/>
                <participants group_id="P2" count="127"/>
                <participants group_id="P3" count="138"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost Enrollment</title>
              <participants_list>
                <participants group_id="P1" count="83"/>
                <participants group_id="P2" count="82"/>
                <participants group_id="P3" count="86"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Less than 31 days of follow-up</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="45"/>
                <participants group_id="P3" count="52"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Low Intensity</title>
          <description>All participants randomized to this arm will receive quarterly educational mailings and limited telephonic outreach delivered by a pharmacist focused on insulin adherence and glycemic control.
Low intensity: Low intensity telepharmacy outreach</description>
        </group>
        <group group_id="B2">
          <title>Moderate Intensity</title>
          <description>Participants will receive all intervention components as in the low-intensity arm but will receive more frequent pharmacist follow-up and the option of enrolling in a text-messaging program. The pharmacist will also provide limited follow-up with the participant’s provider. Only 60% of participants randomized will be targeted to receive the intervention based on adherence risk score.
Moderate intensity: Moderate intensity telepharmacy outreach</description>
        </group>
        <group group_id="B3">
          <title>High Intensity</title>
          <description>Participants will receive all intervention components as in the moderate-intensity arm but will receive more frequent pharmacist follow-up. The pharmacist will also provide more follow-up with the participant’s provider and/or pharmacist. Only 40% of participants randomized will be targeted to receive the intervention based on adherence risk score and baseline disease control.
High intensity: High intensity telepharmacy outreach</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1861"/>
            <count group_id="B2" value="1873"/>
            <count group_id="B3" value="1862"/>
            <count group_id="B4" value="5596"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.1" spread="11.0"/>
                    <measurement group_id="B2" value="55.6" spread="11.3"/>
                    <measurement group_id="B3" value="55.9" spread="10.7"/>
                    <measurement group_id="B4" value="55.9" spread="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="751"/>
                    <measurement group_id="B2" value="738"/>
                    <measurement group_id="B3" value="763"/>
                    <measurement group_id="B4" value="2252"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1110"/>
                    <measurement group_id="B2" value="1135"/>
                    <measurement group_id="B3" value="1099"/>
                    <measurement group_id="B4" value="3344"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1861"/>
                    <measurement group_id="B2" value="1873"/>
                    <measurement group_id="B3" value="1862"/>
                    <measurement group_id="B4" value="5596"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hemoglobin A1c</title>
          <units>% of glycated hemoglobin (A1c)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.5" spread="1.8"/>
                    <measurement group_id="B2" value="8.5" spread="1.8"/>
                    <measurement group_id="B3" value="8.6" spread="1.8"/>
                    <measurement group_id="B4" value="8.5" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>At least 1 HbA1c value available</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="663"/>
                    <measurement group_id="B2" value="640"/>
                    <measurement group_id="B3" value="642"/>
                    <measurement group_id="B4" value="1945"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Short or rapid-acting insulin use</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="954"/>
                    <measurement group_id="B2" value="930"/>
                    <measurement group_id="B3" value="965"/>
                    <measurement group_id="B4" value="2849"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of basal insulin claims</title>
          <units>Basal insulin claims</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.6" spread="1.9"/>
                    <measurement group_id="B2" value="2.6" spread="1.8"/>
                    <measurement group_id="B3" value="2.6" spread="1.9"/>
                    <measurement group_id="B4" value="2.6" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Use of adjunct oral hypoglycemic</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1220"/>
                    <measurement group_id="B2" value="1242"/>
                    <measurement group_id="B3" value="1227"/>
                    <measurement group_id="B4" value="3689"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypoglycemia</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                    <measurement group_id="B2" value="88"/>
                    <measurement group_id="B3" value="87"/>
                    <measurement group_id="B4" value="261"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ketoacidosis</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="41"/>
                    <measurement group_id="B4" value="143"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Retinopathy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="184"/>
                    <measurement group_id="B2" value="156"/>
                    <measurement group_id="B3" value="170"/>
                    <measurement group_id="B4" value="510"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nephropathy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Neuropathy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="431"/>
                    <measurement group_id="B2" value="419"/>
                    <measurement group_id="B3" value="412"/>
                    <measurement group_id="B4" value="1262"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Coronary artery disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="391"/>
                    <measurement group_id="B2" value="405"/>
                    <measurement group_id="B3" value="382"/>
                    <measurement group_id="B4" value="1178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1381"/>
                    <measurement group_id="B2" value="1409"/>
                    <measurement group_id="B3" value="1429"/>
                    <measurement group_id="B4" value="4219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hyperlipidemia</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1278"/>
                    <measurement group_id="B2" value="1248"/>
                    <measurement group_id="B3" value="1275"/>
                    <measurement group_id="B4" value="3801"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Congestive heart failure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="129"/>
                    <measurement group_id="B2" value="147"/>
                    <measurement group_id="B3" value="136"/>
                    <measurement group_id="B4" value="412"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stroke/Transient ischemic attack</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="95"/>
                    <measurement group_id="B2" value="102"/>
                    <measurement group_id="B3" value="103"/>
                    <measurement group_id="B4" value="300"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Obesity</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="461"/>
                    <measurement group_id="B2" value="472"/>
                    <measurement group_id="B3" value="497"/>
                    <measurement group_id="B4" value="1430"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Asthma/COPD</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="254"/>
                    <measurement group_id="B2" value="244"/>
                    <measurement group_id="B3" value="226"/>
                    <measurement group_id="B4" value="724"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cancer</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="235"/>
                    <measurement group_id="B2" value="221"/>
                    <measurement group_id="B3" value="220"/>
                    <measurement group_id="B4" value="676"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Liver Disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="130"/>
                    <measurement group_id="B2" value="142"/>
                    <measurement group_id="B3" value="138"/>
                    <measurement group_id="B4" value="410"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic Kidney Disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1227"/>
                    <measurement group_id="B2" value="1222"/>
                    <measurement group_id="B3" value="1204"/>
                    <measurement group_id="B4" value="3653"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Depression</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="143"/>
                    <measurement group_id="B2" value="135"/>
                    <measurement group_id="B3" value="134"/>
                    <measurement group_id="B4" value="412"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Dementia</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="36"/>
                    <measurement group_id="B4" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Acute Stress</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="57"/>
                    <measurement group_id="B4" value="187"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Days hospitalized</title>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.17" spread="11.1"/>
                    <measurement group_id="B2" value="2.2" spread="10.1"/>
                    <measurement group_id="B3" value="2.0" spread="7.6"/>
                    <measurement group_id="B4" value="2.1" spread="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of Hospitalizations</title>
          <units>Hospitalizations</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.3" spread="0.9"/>
                    <measurement group_id="B2" value="0.3" spread="1.3"/>
                    <measurement group_id="B3" value="0.3" spread="0.8"/>
                    <measurement group_id="B4" value="0.3" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of Office visits</title>
          <units>Office Visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1861"/>
                    <count group_id="B2" value="1873"/>
                    <count group_id="B3" value="1862"/>
                    <count group_id="B4" value="5596"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.5" spread="8.0"/>
                    <measurement group_id="B2" value="9.3" spread="7.6"/>
                    <measurement group_id="B3" value="9.3" spread="7.7"/>
                    <measurement group_id="B4" value="9.3" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Insulin Persistence</title>
        <description>Percentage of participants who were non-persistent if they did not refill insulin before a set threshold of time over the entire follow-up period</description>
        <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Intensity</title>
            <description>All participants randomized to this arm will receive quarterly educational mailings and limited telephonic outreach delivered by a pharmacist focused on insulin adherence and glycemic control.
Low intensity: Low intensity telepharmacy outreach</description>
          </group>
          <group group_id="O2">
            <title>Moderate Intensity</title>
            <description>Participants will receive all intervention components as in the low-intensity arm but will receive more frequent pharmacist follow-up and the option of enrolling in a text-messaging program. The pharmacist will also provide limited follow-up with the participant’s provider. Only 60% of participants randomized will be targeted to receive the intervention based on adherence risk score.
Moderate intensity: Moderate intensity telepharmacy outreach</description>
          </group>
          <group group_id="O3">
            <title>High Intensity</title>
            <description>Participants will receive all intervention components as in the moderate-intensity arm but will receive more frequent pharmacist follow-up. The pharmacist will also provide more follow-up with the participant’s provider and/or pharmacist. Only 40% of participants randomized will be targeted to receive the intervention based on adherence risk score and baseline disease control.
High intensity: High intensity telepharmacy outreach</description>
          </group>
        </group_list>
        <measure>
          <title>Insulin Persistence</title>
          <description>Percentage of participants who were non-persistent if they did not refill insulin before a set threshold of time over the entire follow-up period</description>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1861"/>
                <count group_id="O2" value="1873"/>
                <count group_id="O3" value="1862"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4"/>
                    <measurement group_id="O2" value="4.7"/>
                    <measurement group_id="O3" value="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.88</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.75</ci_lower_limit>
            <ci_upper_limit>1.03</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.91</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.77</ci_lower_limit>
            <ci_upper_limit>1.06</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Glycated Hemoglobin Level (HbA1c)</title>
        <description>The percent change in HbA1c level between the latest baseline value to the latest follow up value, among those with at least 1 baseline HbA1c available.</description>
        <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Intensity</title>
            <description>All participants randomized to this arm will receive quarterly educational mailings and limited telephonic outreach delivered by a pharmacist focused on insulin adherence and glycemic control.
Low intensity: Low intensity telepharmacy outreach</description>
          </group>
          <group group_id="O2">
            <title>Moderate Intensity</title>
            <description>Participants will receive all intervention components as in the low-intensity arm but will receive more frequent pharmacist follow-up and the option of enrolling in a text-messaging program. The pharmacist will also provide limited follow-up with the participant’s provider. Only 60% of participants randomized will be targeted to receive the intervention based on adherence risk score.
Moderate intensity: Moderate intensity telepharmacy outreach</description>
          </group>
          <group group_id="O3">
            <title>High Intensity</title>
            <description>Participants will receive all intervention components as in the moderate-intensity arm but will receive more frequent pharmacist follow-up. The pharmacist will also provide more follow-up with the participant’s provider and/or pharmacist. Only 40% of participants randomized will be targeted to receive the intervention based on adherence risk score and baseline disease control.
High intensity: High intensity telepharmacy outreach</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Glycated Hemoglobin Level (HbA1c)</title>
          <description>The percent change in HbA1c level between the latest baseline value to the latest follow up value, among those with at least 1 baseline HbA1c available.</description>
          <units>Percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="663"/>
                <count group_id="O2" value="640"/>
                <count group_id="O3" value="642"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="1.48"/>
                    <measurement group_id="O2" value="-0.21" spread="1.37"/>
                    <measurement group_id="O3" value="-0.31" spread="1.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.15</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.34</ci_lower_limit>
            <ci_upper_limit>0.05</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.25</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.43</ci_lower_limit>
            <ci_upper_limit>-0.06</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health Care Spending</title>
        <description>Health care spending includes prescription medications, nondrug medical services, and the combination of these two factors over the entire follow-up period</description>
        <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Intensity</title>
            <description>All participants randomized to this arm will receive quarterly educational mailings and limited telephonic outreach delivered by a pharmacist focused on insulin adherence and glycemic control.
Low intensity: Low intensity telepharmacy outreach</description>
          </group>
          <group group_id="O2">
            <title>Moderate Intensity</title>
            <description>Participants will receive all intervention components as in the low-intensity arm but will receive more frequent pharmacist follow-up and the option of enrolling in a text-messaging program. The pharmacist will also provide limited follow-up with the participant’s provider. Only 60% of participants randomized will be targeted to receive the intervention based on adherence risk score.
Moderate intensity: Moderate intensity telepharmacy outreach</description>
          </group>
          <group group_id="O3">
            <title>High Intensity</title>
            <description>Participants will receive all intervention components as in the moderate-intensity arm but will receive more frequent pharmacist follow-up. The pharmacist will also provide more follow-up with the participant’s provider and/or pharmacist. Only 40% of participants randomized will be targeted to receive the intervention based on adherence risk score and baseline disease control.
High intensity: High intensity telepharmacy outreach</description>
          </group>
        </group_list>
        <measure>
          <title>Health Care Spending</title>
          <description>Health care spending includes prescription medications, nondrug medical services, and the combination of these two factors over the entire follow-up period</description>
          <units>Dollars</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1861"/>
                <count group_id="O2" value="1873"/>
                <count group_id="O3" value="1862"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22616" spread="49250"/>
                    <measurement group_id="O2" value="23284" spread="49094"/>
                    <measurement group_id="O3" value="22545" spread="44448"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.95</ci_lower_limit>
            <ci_upper_limit>1.11</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.92</ci_lower_limit>
            <ci_upper_limit>1.06</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Physician Office Visits</title>
        <description>Number of all-cause physician office visits over the entire follow-up period</description>
        <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Intensity</title>
            <description>All participants randomized to this arm will receive quarterly educational mailings and limited telephonic outreach delivered by a pharmacist focused on insulin adherence and glycemic control.
Low intensity: Low intensity telepharmacy outreach</description>
          </group>
          <group group_id="O2">
            <title>Moderate Intensity</title>
            <description>Participants will receive all intervention components as in the low-intensity arm but will receive more frequent pharmacist follow-up and the option of enrolling in a text-messaging program. The pharmacist will also provide limited follow-up with the participant’s provider. Only 60% of participants randomized will be targeted to receive the intervention based on adherence risk score.
Moderate intensity: Moderate intensity telepharmacy outreach</description>
          </group>
          <group group_id="O3">
            <title>High Intensity</title>
            <description>Participants will receive all intervention components as in the moderate-intensity arm but will receive more frequent pharmacist follow-up. The pharmacist will also provide more follow-up with the participant’s provider and/or pharmacist. Only 40% of participants randomized will be targeted to receive the intervention based on adherence risk score and baseline disease control.
High intensity: High intensity telepharmacy outreach</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Physician Office Visits</title>
          <description>Number of all-cause physician office visits over the entire follow-up period</description>
          <units>Physician office visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1861"/>
                <count group_id="O2" value="1873"/>
                <count group_id="O3" value="1862"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.66" spread="7.29"/>
                    <measurement group_id="O2" value="7.62" spread="7.17"/>
                    <measurement group_id="O3" value="7.50" spread="7.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.97</ci_lower_limit>
            <ci_upper_limit>1.02</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.98</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.96</ci_lower_limit>
            <ci_upper_limit>1.00</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Emergency Room Visits</title>
        <description>Number of all-cause emergency room visits over the entire follow-up period</description>
        <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Intensity</title>
            <description>All participants randomized to this arm will receive quarterly educational mailings and limited telephonic outreach delivered by a pharmacist focused on insulin adherence and glycemic control.
Low intensity: Low intensity telepharmacy outreach</description>
          </group>
          <group group_id="O2">
            <title>Moderate Intensity</title>
            <description>Participants will receive all intervention components as in the low-intensity arm but will receive more frequent pharmacist follow-up and the option of enrolling in a text-messaging program. The pharmacist will also provide limited follow-up with the participant’s provider. Only 60% of participants randomized will be targeted to receive the intervention based on adherence risk score.
Moderate intensity: Moderate intensity telepharmacy outreach</description>
          </group>
          <group group_id="O3">
            <title>High Intensity</title>
            <description>Participants will receive all intervention components as in the moderate-intensity arm but will receive more frequent pharmacist follow-up. The pharmacist will also provide more follow-up with the participant’s provider and/or pharmacist. Only 40% of participants randomized will be targeted to receive the intervention based on adherence risk score and baseline disease control.
High intensity: High intensity telepharmacy outreach</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Emergency Room Visits</title>
          <description>Number of all-cause emergency room visits over the entire follow-up period</description>
          <units>ER visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1861"/>
                <count group_id="O2" value="1873"/>
                <count group_id="O3" value="1862"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="1.00"/>
                    <measurement group_id="O2" value="0.43" spread="4.40"/>
                    <measurement group_id="O3" value="0.30" spread="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.38</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.24</ci_lower_limit>
            <ci_upper_limit>1.53</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.96</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.85</ci_lower_limit>
            <ci_upper_limit>1.07</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Hospitalizations</title>
        <description>Number of All-cause hospitalizations over the entire follow-up period</description>
        <time_frame>From 1 month (30 days) after randomization through 12 months (365 days) after randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Intensity</title>
            <description>All participants randomized to this arm will receive quarterly educational mailings and limited telephonic outreach delivered by a pharmacist focused on insulin adherence and glycemic control.
Low intensity: Low intensity telepharmacy outreach</description>
          </group>
          <group group_id="O2">
            <title>Moderate Intensity</title>
            <description>Participants will receive all intervention components as in the low-intensity arm but will receive more frequent pharmacist follow-up and the option of enrolling in a text-messaging program. The pharmacist will also provide limited follow-up with the participant’s provider. Only 60% of participants randomized will be targeted to receive the intervention based on adherence risk score.
Moderate intensity: Moderate intensity telepharmacy outreach</description>
          </group>
          <group group_id="O3">
            <title>High Intensity</title>
            <description>Participants will receive all intervention components as in the moderate-intensity arm but will receive more frequent pharmacist follow-up. The pharmacist will also provide more follow-up with the participant’s provider and/or pharmacist. Only 40% of participants randomized will be targeted to receive the intervention based on adherence risk score and baseline disease control.
High intensity: High intensity telepharmacy outreach</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Hospitalizations</title>
          <description>Number of All-cause hospitalizations over the entire follow-up period</description>
          <units>Hospitalizations</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1861"/>
                <count group_id="O2" value="1873"/>
                <count group_id="O3" value="1862"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" spread="0.63"/>
                    <measurement group_id="O2" value="0.23" spread="0.72"/>
                    <measurement group_id="O3" value="0.21" spread="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.22</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.06</ci_lower_limit>
            <ci_upper_limit>1.41</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.14</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.99</ci_lower_limit>
            <ci_upper_limit>1.32</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>We did not collect adverse event data (no investigational drug studied). Adverse events were not a pre-specified outcome for the trial. We also did not measure or evaluate mortality.</time_frame>
      <desc>We did not collect adverse event data (no investigational drug studied). Adverse events were not a pre-specified outcome for the trial. We also did not measure or evaluate mortality.</desc>
      <group_list>
        <group group_id="E1">
          <title>Low Intensity</title>
          <description>All participants randomized to this arm will receive quarterly educational mailings and limited telephonic outreach delivered by a pharmacist focused on insulin adherence and glycemic control.
Low intensity: Low intensity telepharmacy outreach</description>
        </group>
        <group group_id="E2">
          <title>Moderate Intensity</title>
          <description>Participants will receive all intervention components as in the low-intensity arm but will receive more frequent pharmacist follow-up and the option of enrolling in a text-messaging program. The pharmacist will also provide limited follow-up with the participant’s provider. Only 60% of participants randomized will be targeted to receive the intervention based on adherence risk score.
Moderate intensity: Moderate intensity telepharmacy outreach</description>
        </group>
        <group group_id="E3">
          <title>High Intensity</title>
          <description>Participants will receive all intervention components as in the moderate-intensity arm but will receive more frequent pharmacist follow-up. The pharmacist will also provide more follow-up with the participant’s provider and/or pharmacist. Only 40% of participants randomized will be targeted to receive the intervention based on adherence risk score and baseline disease control.
High intensity: High intensity telepharmacy outreach</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Niteesh K. Choudhry, MD, PhD</name_or_title>
      <organization>Brigham and Women's Hospital</organization>
      <phone>617-278-0930</phone>
      <email>nkchoudhry@bwh.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

